These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 24055050)

  • 41. Is letrozole during ovarian stimulation useful in breast cancer patients undergoing fertility preservation to reduce early luteal progesterone levels following GnRH-agonist trigger?
    Lalami I; Labrosse J; Cedrin-Durnerin I; Comtet M; Vinolas C; Krief F; Sifer C; Peigne M; Grynberg M
    Reprod Biol Endocrinol; 2022 Jun; 20(1):87. PubMed ID: 35690817
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of letrozole added to gonadotropins in controlled ovarian stimulation protocols on the yield and maturity of retrieved oocytes.
    Ben-Haroush A; Wertheimer A; Klochendler E; Sapir O; Shufaro Y; Oron G
    Gynecol Endocrinol; 2019 Apr; 35(4):324-327. PubMed ID: 30596311
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What is the optimal follicular size before triggering ovulation in intrauterine insemination cycles with clomiphene citrate or letrozole? An analysis of 988 cycles.
    Palatnik A; Strawn E; Szabo A; Robb P
    Fertil Steril; 2012 May; 97(5):1089-94.e1-3. PubMed ID: 22459633
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-Mullerian hormone and antral follicle count as predictors for embryo/oocyte cryopreservation cycle outcomes in breast cancer patients stimulated with letrozole and follicle stimulating hormone.
    Lee S; Ozkavukcu S; Heytens E; Moy F; Alappat RM; Oktay K
    J Assist Reprod Genet; 2011 Jul; 28(7):651-6. PubMed ID: 21573682
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oocyte accumulation for fertility preservation in women with benign ovarian tumours with a history of previous surgery, multiple or large cysts.
    Legrand C; Keller L; Collinet P; Barbotin AL; Béhal H; Rubod C; Decanter C
    Reprod Biomed Online; 2021 Aug; 43(2):205-214. PubMed ID: 34247989
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Minimal stimulation using gonadotropin combined with clomiphene citrate or letrozole for intrauterine insemination.
    Yun BH; Chon SJ; Park JH; Seo SK; Cho S; Choi YS; Kim SH; Lee BS
    Yonsei Med J; 2015 Mar; 56(2):490-6. PubMed ID: 25684000
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro fertilization treatments with the use of clomiphene citrate or letrozole.
    Haas J; Casper RF
    Fertil Steril; 2017 Oct; 108(4):568-571. PubMed ID: 28965550
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Twin delivery after IVF-ET with variable dose letrozole-FSH protocol of lower estradiol in a patient previously treated for breast cancer: a case report.
    Zhang CJ; Zhang Y; Hu GZ; Diao H
    Eur J Gynaecol Oncol; 2016; 37(2):278-81. PubMed ID: 27172763
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-Term Safety of Letrozole and Gonadotropin Stimulation for Fertility Preservation in Women With Breast Cancer.
    Kim J; Turan V; Oktay K
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1364-71. PubMed ID: 26751194
    [TBL] [Abstract][Full Text] [Related]  

  • 50. GnRH antagonist and letrozole co-treatment in diminished ovarian reserve patients: a proof-of-concept study.
    Olgan S; Humaidan P
    Reprod Biol; 2017 Mar; 17(1):105-110. PubMed ID: 28173995
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Letrozole for ovulation induction and fertility preservation by embryo cryopreservation in young women with endometrial carcinoma.
    Azim A; Oktay K
    Fertil Steril; 2007 Sep; 88(3):657-64. PubMed ID: 17428480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Random-start controlled ovarian hyperstimulation with letrozole for fertility preservation in cancer patients: case series and review of literature.
    Keskin U; Ercan CM; Yilmaz A; Babacan A; Korkmaz C; Duru NK; Ergun A
    J Pak Med Assoc; 2014 Jul; 64(7):830-2. PubMed ID: 25255597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessing ovarian stimulation with letrozole and levonorgestrel intrauterine system after combined fertility-sparing approach for atypical endometrial lesions: a retrospective case-control study.
    Gallo A; Di Spiezio Sardo A; Conforti A; Iorio GG; Zizolfi B; Buonfantino C; De Angelis MC; Strina I; Marrone V; Bifulco G; Alviggi C
    Reprod Biomed Online; 2024 May; 48(5):103750. PubMed ID: 38430660
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer?
    Revelli A; Porcu E; Levi Setti PE; Delle Piane L; Merlo DF; Anserini P
    Gynecol Endocrinol; 2013 Nov; 29(11):993-6. PubMed ID: 24000936
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Fertility preserving methods in women with breast cancer before gonadotoxic therapy].
    Halászová N; Crha I; Huser M; Weinberger V; Žáková J; Ješeta M; Lousová E; Filipinská E; Ventruba P
    Ceska Gynekol; 2017; 82(4):287-292. PubMed ID: 28925272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
    Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
    Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial: baseline characteristics.
    Diamond MP; Legro RS; Coutifaris C; Alvero R; Robinson RD; Casson P; Christman GM; Ager J; Huang H; Hansen KR; Baker V; Usadi R; Seungdamrong A; Bates GW; Rosen RM; Haisonleder D; Krawetz SA; Barnhart K; Trussell JC; Jin Y; Santoro N; Eisenberg E; Zhang H;
    Fertil Steril; 2015 Apr; 103(4):962-973.e4. PubMed ID: 25707331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ovarian stimulation for fertility preservation in women with cancer: A systematic review and meta-analysis comparing random and conventional starts.
    Alexander VM; Martin CE; Schelble AP; Laufer AB; Hardi A; McKenzie LJ; Hipp HS; Kawwass JF; Spencer JB; Jungheim ES
    J Gynecol Obstet Hum Reprod; 2021 Oct; 50(8):102080. PubMed ID: 33545413
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of tamoxifene-controlled ovarian hyperstimulation for fertility preservation before breast cancer treatment: A prospective cohort study with a 5-year follow-up.
    Dezellus A; Mirallie S; Leperlier F; Sauterey B; Bouet PE; Dessaint A; Duros S; Gremeau AS; Mouret-Reynier MA; Durand LM; Venat L; De Blay P; Robert M; Freour T; Campone M; Blanc-Lapierre A; Bordes V
    Breast; 2024 Oct; 77():103776. PubMed ID: 39167853
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation.
    Oktay K; Demirtas E; Son WY; Lostritto K; Chian RC; Tan SL
    Fertil Steril; 2008 Jan; 89(1):228.e19-22. PubMed ID: 17517403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.